Investigators introduced a CD33-directed third-generation CAR T cell product for the treatment of patients with acute myeloid leukemia.
[International Journal of Cancer]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.